<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Obstetrics and Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics and Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство и гинекология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0300-9092</issn><issn publication-format="electronic">2412-5679</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">246531</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">AUTOANTIBODIES TO GONADOTROPIC HORMONES AND TESTOSTERONE IN MALE INFERTILITY</article-title><trans-title-group xml:lang="ru"><trans-title>АУТОАНТИТЕЛА К ГОНАДОТРОПНЫМ ГОРМОНАМ И ТЕСТОСТЕРОНУ У МУЖЧИН С БЕСПЛОДИЕМ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>MENZHINSKAYA</surname><given-names>I. V</given-names></name><name xml:lang="ru"><surname>МЕНЖИНСКАЯ</surname><given-names>Ирина Владимировна</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, ст. науч. сотр. лаборатории клинической иммунологии</p></bio><email>i_menzinskaya@oparina4.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>TER-AVANESOV</surname><given-names>G. V</given-names></name><name xml:lang="ru"><surname>ТЕР-АВАНЕСОВ</surname><given-names>Г. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>GAVRILOV</surname><given-names>Yu. A</given-names></name><name xml:lang="ru"><surname>ГАВРИЛОВ</surname><given-names>Ю. А</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>BEZNOSHCHENKO</surname><given-names>O. S</given-names></name><name xml:lang="ru"><surname>БЕЗНОЩЕНКО</surname><given-names>О. С</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>VANKO</surname><given-names>L. V</given-names></name><name xml:lang="ru"><surname>ВАНЬКО</surname><given-names>Л. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>SUKHIKH</surname><given-names>G. T</given-names></name><name xml:lang="ru"><surname>СУХИХ</surname><given-names>Г. Т</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia</institution></aff><aff><institution xml:lang="ru">ФГУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2011-05-15" publication-format="electronic"><day>15</day><month>05</month><year>2011</year></pub-date><issue>5</issue><issue-title xml:lang="en">NO5 (2011)</issue-title><issue-title xml:lang="ru">№5 (2011)</issue-title><fpage>54</fpage><lpage>57</lpage><history><date date-type="received" iso-8601-date="2023-02-17"><day>17</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2011, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2011, ООО «Бионика Медиа»</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/0300-9092/article/view/246531">https://journals.eco-vector.com/0300-9092/article/view/246531</self-uri><abstract xml:lang="en"><p>Objective. To study whether autoantibodies to human chorionic gonadotropin (hCG) and testosterone can be produced in male infertility. Subjects and methods. A study group comprised men with infertility and pathozoospermia (n=71). A control group included fertile men with normozoospermia (n=32). Autoantibodies to hCG and testosterone and IgG subclasses were determined in blood serum by enzyme-linked immunosorbent assay. Results. Production of IgM- and IgG-classes autoantibodies to hCG and testosterone (1-4 subclasses, mainly functionally active IgG1) was found in male infertility. Antibodies to hCG and testosterone were detected more frequently in the infertile men (40.8% and 25.4%, respectively) than in the fertile men (3.1%) (p&lt;0.01). There was a high detection rate of the antibodies in idiopathic male infertility (54.5% and 39.4%, respectively), in patients with astenozoospermia, and/or oligozoospermia, azoospermia. Conclusion. Autoantibodies to hCG and testosterone may be considered as a possible etiological factor of male infertility.</p></abstract><trans-abstract xml:lang="ru"><p>Цель исследования. Изучение возможности продукции аутоантител к хорионическому гонадотропину человека (ХГЧ) и тестостерону у мужчин с бесплодием. Материал и методы. Основную группу составили мужчины с бесплодием (n=71) и патозооспермией, контрольную — фертильные мужчины с нормозооспермией (n=32). В сыворотке крови методом иммуноферментного анализа определяли антитела к ХГЧ, тестостерону и подклассы IgG. Результаты исследования. У мужчин с бесплодием наблюдали продукцию антител к ХГЧ и тестостерону IgM- и IgG-изотипов, четырех подклассов IgG с преобладанием функционально активных IgG1. Антитела к ХГЧ и тестостерону при бесплодии встречались чаще (у 40,8 и 25,4% соответственно), чем у фертильных мужчин (у 3,1%) (p&lt;0,01). Высокая частота выявления антител наблюдалась при идиопатическом бесплодии (у 54,5 и 39,4% соответственно), у пациентов с астенозооспермией, олигозооспермией и азооспермией. Заключение. Антитела к гонадотропинам и тестостерону могут рассматриваться как возможный этиологический фактор мужского бесплодия.</p></trans-abstract><kwd-group xml:lang="en"><kwd>autoantibodies</kwd><kwd>human chorionic gonadotropin</kwd><kwd>testosterone</kwd><kwd>male infertility</kwd><kwd>pathozoospermia</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>аутоантитела</kwd><kwd>хорионический гонадотропин человека</kwd><kwd>тестостерон</kwd><kwd>мужское бесплодие</kwd><kwd>патозооспермия</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Пономарева И.В., Сухих Г.Т., Никитин Э.Б. и др. Аутоантитела к хорионическому гонадотропину человека при привычном невынашивании беременности // Бюл. экспер. биол. — 1996. — № 4. — C. 450—452.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Сухих Г.Т., Божедомов В.А. Мужское бесплодие. — М.: ЭКСМО-Пресс, 2009.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Цырлина Е.В., Порошина Т.Е. Хорионический гонадотропин как маркер трофобластической болезни// Практ. онкол. — 2008. — Т. 9, № 3. — С. 150—159.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Allen R.B., Li A., Landay M.F. et al. Hyperglycosylated human chorionic gonadotropin (HHCG): a novel finding in seminal plasma//Fertil. and Steril. — 2008. — Vol. 90 (suppl.1). — P. S97.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Berger P., Gruschwitz M., Spoettl G. et al. Human chorionic gonadotropin (hCG) in the male reproductive tract// Mol. Cell. Endocrinol. — 2007. — Vol. 260—262. — P. 190—196.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Dirnhofer S., Wick G., Berger P. The suitability of human chorionic gonadotropin (hCG) -based birth-control vaccines// Immunol. Today. — 1994. — Vol. 15, № 10. — P. 469—474.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Moundgal N.R., Jeyakumar M., Krishnamurthy H.N. et al. Development of male contraceptive vaccine- a perspective// Hum. Reprod. Update. — 1997. — Vol. 3, № 4. — P. 335—346.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Ogura T., Mimura Y., Otsuka F. et al. Hypothyroidism associated with anti-human chorionic gonadotropin antibodies secondarily produced by gonadotropin therapy in a case of idiopathic hypothalamic hypogonadism// J. Endocrinol. Invest. — 2003. — Vol. 26, № 11. — P. 1128—1135.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Yao B., Wang J., Liang W. et al. Follicle-stimulating hormone autoantibody is involved in idiopathic spermatogenic dysfunction // Asian J. Androl. — 2008. — Vol. 10, № 6. — P. 915—921.</mixed-citation></ref></ref-list></back></article>
